GRN and COVID-19: Although these results favor the authors to consider PGRN serum levels as an endothelial activator during COVID-19, this study had some limitations, such as a small sample size, patients enrolled were very heterogenous, and most patients had mild/moderate COVID-19 infections, which do not encompass the complete picture of the disease.